Jiunshi Biotechnology

Junshi Biosciences develops and commercializes innovative biopharmaceutical products, focusing on discovering and advancing novel therapies. It targets therapeutic areas including oncology, metabolic disorders, and infectious diseases. The company employs a science-driven approach to develop first-in-class and best-in-class drug candidates through rigorous clinical development and manufacturing.

Established in December 2012 in Shanghai, Junshi Biosciences was founded by its visionary team, including Mr. Zhang. Their insight focused on addressing unmet medical needs through pioneering innovative biopharmaceuticals. This commitment drove early efforts to develop novel biologics, such as their anti-PD-1 monoclonal antibody, aiming for more effective and accessible treatments.

Junshi Biosciences serves global patients with severe conditions, providing therapeutic solutions to enhance outcomes and accessibility. The company’s long-term vision is to be a globally competitive biopharmaceutical leader. It achieves this by pursuing scientific breakthroughs and efficient drug development, aspiring to deliver transformative medicines benefiting a wide patient population worldwide.